onilcamotide (RV001) - Chosa Oncology
http://www.ncbi.nlm.nih.gov/pubmed/40333248
 
On Behalf Of The RhoVac-Study Group; Andreas Røder; Anna Schöllhorn; Anne Rahbech; Cécile Gouttefangeas; Juliane Schuhmacher; Klaus Brasso; Per Thor Straten; Sara Fresnillo Saló; Sara Ram Pedersen; Steffen Wad Jørgensen; Tina Seremet; Valero Andreu Matillas
 
May 7, 2025
 
Next